✦ LIBER ✦

The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group

✍ Scribed by G.F Samelis; D Skarlos; D Bafaloukos; P Kosmidis; A Anagnostopoulos; G Aravantinos; M.A Dimopoulos

Book ID: 117265103
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 104 KB
Volume: 61
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(03)00019-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The combination of estramustine, vinorel

The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: A Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group

✍ Georgios Fotios Samelis; Haralambos Kalofonos; Adamos Adamou; Paris Kosmides; Di 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 106 KB

A phase II trial of estramustine and eto

A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)

✍ Kenneth J. Pienta; Emily I. Fisher; Mario A. Eisenberger; Glenn M. Mills; J. Wen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

BACKGROUND. The combination of oral estramustine and oral etoposide has generated response rates of 40±50% in patients with hormone refractory prostate cancer in single institution trials. This study tested this regimen in a multi-institutional setting. METHODS. Fifty-®ve patients were accrued over

Phase II study of sequential chemotherap

Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer

✍ Galli, L; Fontana, A; Galli, C; Landi, L; Fontana, E; Antonuzzo, A; Andreuccetti 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Paclitaxel by 3-H infusion and carboplat

Paclitaxel by 3-H infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the hellenic cooperative oncology group

✍ G. Fountzilas; A. Athanassiadis; A. Kalogera-Fountzila; G. Aravantinos; D. Bafal 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Taxol in advanced, hormone-refractory ca

Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group

✍ Bruce J. Roth; Patrick J. Loehrer; Beow Yong Yeap; George Wilding; Basil Kasimis 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB 👁 2 views

Combination of topotecan and cisplatin i

Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG)

✍ Christos Christodoulou; Haralambos P. Kalofonos; Evangelos Briasoulis; Dimitrios 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 201 KB